MENU
+Compare
OZEM
ETF ticker: NASDAQ
AS OF
Oct 3 closing price
Price
$28.96
Change
+$0.49 (+1.72%)

OZEM stock forecast, quote, news & analysis

The investment seeks to provide capital appreciation... Show more

Category: #Health
OZEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for OZEM with price predictions
Oct 03, 2025

OZEM in +1.86% Uptrend, growing for three consecutive days on October 03, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where OZEM advanced for three days, in of 90 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 18, 2025. You may want to consider a long position or call options on OZEM as a result. In of 16 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OZEM just turned positive on September 30, 2025. Looking at past instances where OZEM's MACD turned positive, the stock continued to rise in of 10 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 44 cases where OZEM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OZEM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OZEM broke above its upper Bollinger Band on October 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Pfizer (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to provide capital appreciation. The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

Market Cap

The average market capitalization across the Roundhill GLP-1 & Weight Loss ETF ETF is 98.76B. The market cap for tickers in the group ranges from 345.09M to 752.91B. LLY holds the highest valuation in this group at 752.91B. The lowest valued company is ALT at 345.09M.

High and low price notable news

The average weekly price growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF ETF was 9%. For the same ETF, the average monthly price growth was 10%, and the average quarterly price growth was 35%. VKTX experienced the highest price growth at 16%, while SRRK experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF ETF was 47%. For the same stocks of the ETF, the average monthly volume growth was 61% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 80
Price Growth Rating: 47
SMR Rating: 69
Profit Risk Rating: 72
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
OZEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details